top of page
it's where dermatology lives



SARS-COV-2 mRNA vaccines improve clinical responses to immune checkpoint inhibition
In a new study, researchers have identified benefits of SARS-COV-2 mRNA vaccines for cancer patients undergoing immunotherapy. The...
Allan Ryan
Nov 18, 20242 min read


Understanding the NIHB to improve Indigenous skin outcomes
To enhance care for Indigenous dermatology patients, Canadian physicians are being encouraged to familiarize themselves with the...
John Evans
Nov 15, 20241 min read


VIDEO: AI model effective in screening skin cancer
An AI model has been found to be effective in screening melanoma and other skin cancers.
Jeremy Visser
Nov 13, 20241 min read


Strategies to enhance equity, diversity, and inclusion in dermatology
There is a significant discrepancy between population demographics and representation in dermatology resources, and a critical need for...
Allan Ryan
Nov 11, 20242 min read


New AAD project to gather HS patient insights
On Oct. 30, 2024, the American Academy of Dermatology (AAD) announced a new initiative to shed light on hidradenitis suppurativa (HS). In...
John Evans
Nov 8, 20242 min read


Combination dupilumab, abrocitinib effective in treating refractory pediatric AD
A combination of dupilumab and abrocitinib is effective in treating refractory AD in pediatric patients
Jeremy Visser
Nov 6, 20241 min read


Deadline approaching for Dermatology Resident Essay Competition
At the 2024 annual conference of the Canadian Dermatology Association in Ottawa, Dr. Airiss Chan was awarded a book prize for her essay...
Allan Ryan
Nov 4, 20242 min read


JAK inhibitors for alopecia areata
Photo by Thirunavukkarasye-Raveendran via Wikimedia Commons JAK inhibitors are emerging as effective treatments for alopecia areata, said...
Mitch Shannon
Nov 1, 20243 min read
Featured Posts




bottom of page

